4//SEC Filing
Kalnik Matthew W. 4
Accession 0001455244-10-000034
CIK 0000072444other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:50 PM ET
Size
10.9 KB
Accession
0001455244-10-000034
Insider Transaction Report
Form 4
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Transactions
- Other
Common Stock
2009-11-30$2.41/sh+5,404.282$13,000→ 39,523.104 total - Exercise/Conversion
Common Stock
2010-03-02$3.95/sh+2,250$8,888→ 41,773.104 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-03-02−2,250→ 15,750 totalExercise: $3.95Exp: 2015-04-01→ Common Stock (2,250 underlying) - Sale
Common Stock
2010-03-02$5.45/sh−2,250$12,263→ 39,523.104 total
Footnotes (3)
- [F1]Voluntarily reported acquisition under the Issuer's Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3.
- [F2]The acquisition and sale of 2,250 shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F3]One-quarter of this Option became exercisable on April 1, 2009. The remaining three-quarters of the Option will become exercisable in three equal installments on April 1, 2010, April 1, 2011 and April 1, 2012.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001459477
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:50 PM ET
- Size
- 10.9 KB